Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 1
2000 3
2001 1
2002 4
2003 5
2004 1
2005 1
2006 4
2007 4
2008 3
2009 4
2010 4
2011 3
2012 7
2013 1
2014 1
2015 5
2017 1
2019 3
2020 4
2021 3
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Diabetic Kidney Disease.
Caramori ML, Rossing P. Caramori ML, et al. 2022 Aug 3. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. 2022 Aug 3. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. PMID: 25905328 Free Books & Documents. Review.
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Craig JC, Tunnicliffe DJ, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K. Navaneethan SD, et al. Among authors: caramori ml. Ann Intern Med. 2023 Mar;176(3):381-387. doi: 10.7326/M22-2904. Epub 2023 Jan 10. Ann Intern Med. 2023. PMID: 36623286 Free article.
Diabetic nephropathy: diagnosis, prevention, and treatment.
Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Gross JL, et al. Among authors: caramori ml. Diabetes Care. 2005 Jan;28(1):164-76. doi: 10.2337/diacare.28.1.164. Diabetes Care. 2005. PMID: 15616252 Review.
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.
Rossing P, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Khunti K, Liew A, Michos ED, Navaneethan SD, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Zoungas S, Craig JC, Tunnicliffe DJ, Tonelli MA, Cheung M, Earley A, de Boer IH. Rossing P, et al. Among authors: caramori ml. Kidney Int. 2022 Nov;102(5):990-999. doi: 10.1016/j.kint.2022.06.013. Kidney Int. 2022. PMID: 36272755 Free article.
The authors reply.
Caramori ML, Tuttle KR, Tandon N, Tunnicliffe DJ, de Boer IH, Rossing P; Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. Caramori ML, et al. Kidney Int. 2022 Feb;101(2):420-421. doi: 10.1016/j.kint.2021.11.019. Epub 2021 Dec 11. Kidney Int. 2022. PMID: 34906418 No abstract available.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Tuttle KR, Hauske SJ, Canziani ME, Caramori ML, Cherney D, Cronin L, Heerspink HJL, Hugo C, Nangaku M, Rotter RC, Silva A, Shah SV, Sun Z, Urbach D, de Zeeuw D, Rossing P; ASi in CKD group. Tuttle KR, et al. Among authors: caramori ml. Lancet. 2024 Jan 27;403(10424):379-390. doi: 10.1016/S0140-6736(23)02408-X. Epub 2023 Dec 15. Lancet. 2024. PMID: 38109916 Clinical Trial.
Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.
Rossing P, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Fonseca V, Umpierrez GE, Caramori ML, Joseph A, Lambelet M, Lawatscheck R, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Among authors: caramori ml. Diabetes Obes Metab. 2023 Feb;25(2):407-416. doi: 10.1111/dom.14883. Epub 2022 Nov 2. Diabetes Obes Metab. 2023. PMID: 36193847 Free PMC article. Clinical Trial.
Diabetes and nephropathy.
Caramori ML, Mauer M. Caramori ML, et al. Curr Opin Nephrol Hypertens. 2003 May;12(3):273-82. doi: 10.1097/00041552-200305000-00008. Curr Opin Nephrol Hypertens. 2003. PMID: 12698065 Review.
69 results